Intrinsiqs

Is Arcutis Biotherapeutics, Inc. overvalued?

Arcutis Biotherapeutics, Inc. (ARQT) — key valuation metrics and fundamentals.

No verdict
Price
$25.83
Fair value
Current P/E
Normal P/E
Market cap
$3.23B
Dividend yield
0.0%
Return on equity
15.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ARQT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.